Navigation Links
Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
Date:6/22/2013

arge cardiovascular outcome trial.

About Diabetes
Approximately 25.8 million Americans2 and an estimated 371 million people worldwide3 have type 1 or type 2 diabetes. T2D is the most common type, accounting for an estimated 90 to 95 percent of all diabetes cases.2 Diabetes is a chronic condition that occurs when the body does not properly produce or use the hormone insulin4. Diabetes was estimated to cost the U.S. $245 billion in direct medical costs and reduced productivity in 2012.5

Boehringer Ingelheim and Eli Lilly and Company
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in the field of diabetes that centers on three compounds representing several of the largest diabetes treatment classes. This alliance leverages the companies' strengths as two of the world's leading pharmaceutical companies, combining Boehringer Ingelheim's solid track record of research-driven innovation and Lilly's innovative research, experience, and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of people with diabetes and stand together to focus on patient needs. Find out more about the alliance at www.boehringer-ingelheim.com or www.lilly.com.

About Boehringer Ingelheim
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned co
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
2. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
3. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
4. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
6. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
7. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
8. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
10. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
11. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... , Aug. 21, 2014 The spinal column ... the human body. Signals carried to and from the brain ... skills and nervous system. Injury or ailment here can be ... with a loss of control over their body. Though back ... a person,s life, there are more options available to make ...
(Date:8/21/2014)... -- Publicis Groupe customer engagement agency Rosetta today ... Industry Group Leader, has been featured in the 2014 ... people in the life-sciences industry. Those chosen for this ... technology, creativity, strategy and medicine. Hartley ... its leading Rosetta Consulting practice. In 2012, she was ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Shannon Hartley Shines in PharmaVOICE 100 2
... ROSA, Calif. , Feb. 16 Osseon Therapeutics Inc. ... Europe . The procedures were performed in Milan, Italy . ... independent medical device distributor in Europe , Osseoplasty cases are ... United Kingdom , Germany and Spain . , ...
... N.J. , Feb. 16 IntegriChain, Inc., ... the launch of its new DNA: Dynamic NextGen ... helps pharmaceutical manufacturers unlock the value of Direct Data ... Data includes those data assets typically provided to ...
Cached Medicine Technology:Osseon Launches in Europe 2IntegriChain Launches DNA: Dynamic NextGen Analytics(TM) Platform 2IntegriChain Launches DNA: Dynamic NextGen Analytics(TM) Platform 3
(Date:8/21/2014)... To sexually objectify a woman is to focus on ... sexual pleasure rather than viewing her as a complete ... long been considered a problem in the media, how ... in Psychology of Women Quarterly , a SAGE ... body is related to higher incidents of sexual pressure ...
(Date:8/21/2014)... London, UK (PRWEB) August 21, 2014 ... from USD 15.6 billion in 2014 and reach USD ... during the forecast period. The drivers of such growth ... products, rising obese and diabetic population, and surging ageing ... costs of state-of-the-art wound care products. Region-wise, North America ...
(Date:8/21/2014)... Revista, a one-stop source for healthcare ... is “on a roll.” Today, the Annapolis-based company ... Southeast, Mid-Atlantic and Midwest areas of the country ... available, comprehensive medical property database tracking these regions. ... including existing and recently added, is 34,549. This ...
(Date:8/21/2014)... News) -- Using two types of polio vaccines seems ... boost efforts to eradicate polio, a new study shows. ... found that giving the Salk inactivated poliovirus vaccine (IPV) ... live-attenuated oral poliovirus vaccine (OPV) appeared to improve their ... findings, reported in the Aug. 22 issue of the ...
(Date:8/21/2014)... (CHEST) announces the immediate release of Care of ... Disasters: CHEST Consensus Statement today in the Online ... while the global health-care community cares for patients ... to guide ethical decision-making, coordination of care, resource ... developed by over 100 clinicians and experts representing ...
Breaking Medicine News(10 mins):Health News:Objectification in romantic relationships related to sexual pressure and coercion 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 2Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 4Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 5Health News:Two Polio Vaccines May Give Greater Protection Against Crippling Disease 2Health News:CHEST releases new expert guidance in care of the critically ill and injured 2
... PHILADELPHIA, Sept. 28 Independence Blue Cross,announces it ... System,and St. Mary Medical Center, both part of ... 2007. The Mercy Health System includes Mercy ... St. Agnes Continuing,Care Center, and Nazareth Hospital, as ...
... Intelligence,executive once said: "CI is like oxygen. You have ... need it is when it is in short supply." ... or have been a,client for such insights, you understand ... position in the,marketplace. By delivering high-impact analyses on competitors, ...
... New Option To Treat Morbid Obesity, CINCINNATI, ... U.S. Food and Drug Administration (FDA) approved for,marketing ... for,weight reduction and improvement in obesity-related health conditions, ... obesity. The REALIZE Band is an innovative ...
... BOZEMAN, Mont. -- Stable flies are the latest suspect that ... hundreds of pelican chicks at the Medicine Lake National Wildlife ... 1,000 pelican chicks in 2003, averaged 400 in each of ... year. , Veterinary entomologist Greg Johnson of Montana State University ...
... that minority patients generally receive a lower quality ... can these disparities be reduced? A supplement to ... and Review, published by SAGE, thoroughly explores the ... question. , The supplement features research from the ...
... ON, Sept. 28 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC ... the next,generation of therapeutic products for inflammatory and ... million of,liabilities. Pursuant to a unanimous resolution ... to the Company by its directors, officers and ...
Cached Medicine News:Health News:Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center 2Health News:Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center 3Health News:Uncover Key Competitive Intelligence Insights in Webinars Hosted by Best Practices 2Health News:FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity 2Health News:FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity 3Health News:FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity 4Health News:Montana State University researchers investigate new suspect in West Nile deaths of pelicans 2
DSL-10-49200 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in serum. This kit requires no sample extraction or pretreatment...
RIA kit for the quantitative determination of autoantibodies to steroid 21-hydroxylase (21-OH) in serum....
... volume for use with 4, 8, or 12 ... withdrawal of nearly all of the solution. Corners ... Made of natural virgin polystyrene containing no regrinds. ... by irradiation. Dimensions: 78 mm W x 152 ...
... Increased volume for use with 4, ... and V-shaped bottom permits withdrawal of nearly ... lips to dispose of excess solution. Made ... Non-sterile. Dimensions: 78 mm W x 152 ...
Medicine Products: